Ting Luo

1.3k total citations · 1 hit paper
62 papers, 539 citations indexed

About

Ting Luo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Ting Luo has authored 62 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Oncology, 21 papers in Pulmonary and Respiratory Medicine and 17 papers in Cancer Research. Recurrent topics in Ting Luo's work include HER2/EGFR in Cancer Research (21 papers), Cancer Treatment and Pharmacology (18 papers) and Advanced Breast Cancer Therapies (14 papers). Ting Luo is often cited by papers focused on HER2/EGFR in Cancer Research (21 papers), Cancer Treatment and Pharmacology (18 papers) and Advanced Breast Cancer Therapies (14 papers). Ting Luo collaborates with scholars based in China, United States and Sweden. Ting Luo's co-authors include Hong Zheng, Xiaorong Zhong, Ping He, Xiaoting Wu, Kunrui Zhu, Xinyi Yang, Yong Luo, Biyun Wang, Qin-Lai Huang and Mingming Zhang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Ting Luo

53 papers receiving 535 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

HER2-targeted therapies in cancer: a systematic review

2024 57 citations Kunrui Zhu, Xinyi Yang et al. Biomarker Research profile →

Peers

Ting Luo

ONCOL

PRM

RNMI

Maria Laura Canale Italy

Shinsuke Saisho Japan

Bruce Keith United States

Rakesh Chopra India

Hakim Mahammedi France

Hong Ren China

Hannah Hazard‐Jenkins United States

Anatole Cessot France

Tetsuo Ishizaki Japan

Maria Laura Canale Italy

Ting Luo

204 ×0.8

ONCOL

209 ×1.3

PRM

59 ×0.5

175 ×1.5

116 ×1.2

RNMI

Citations per year, relative to Ting Luo Ting Luo (= 1×) peers Maria Laura Canale

Countries citing papers authored by Ting Luo

Since Specialization

Citations

This map shows the geographic impact of Ting Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ting Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ting Luo more than expected).

Fields of papers citing papers by Ting Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ting Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ting Luo. The network helps show where Ting Luo may publish in the future.

Co-authorship network of co-authors of Ting Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Ting Luo. A scholar is included among the top collaborators of Ting Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ting Luo. Ting Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhao, Miaomiao, Ting Luo, Jialin Cui, et al.. (2025). Prediction of survival in acute myeloid leukemia patients by extracellular to intracellular water ratio and sarcopenia: development and validation of a novel nomogram. Annals of Hematology. 104(2). 985–996. 1 indexed citations

Liu, Defang, Yan Jiao, Ting Luo, & Ling Yang. (2025). Association between C-reactive protein and hemoglobin in US rheumatoid arthritis patients based on NHANES data analysis. Scientific Reports. 15(1). 8905–8905.

Luo, Ting, et al.. (2025). Association between periodontitis and gastrointestinal cancer risk and prognosis: evidence from a nested case–control study in Southwest China. European journal of medical research. 30(1). 225–225. 1 indexed citations

Luo, Ting, Janneke Berecki‐Gisolf, & Stuart Marshall. (2025). Incidence of peri‐operative peripheral nerve injuries associated with general and regional anaesthesia: an observational study. Anaesthesia.

Luo, Ting, et al.. (2024). Efficacy and safety of eribulin mesylate in patients with locally advanced or metastatic breast cancer previously treated with anthracycline/taxanes. Cancer Medicine. 13(10). e7295–e7295. 2 indexed citations

Gan, Fengxia, Ting Luo, Qun Lin, et al.. (2024). Patient‐reported outcome and survival in premenopausal hormone receptor‐positive breast cancer patients at moderate to high risk: comparing toremifene with aromatase inhibitor in a real‐world study. SHILAP Revista de lepidopterología. 5(10). e698–e698.

Zhu, Kunrui, et al.. (2024). HER2-targeted therapies in cancer: a systematic review. Biomarker Research. 12(1). 57 indexed citations breakdown →

Zhang, Qiongwen, Ping He, Xi Yan, et al.. (2023). Real-world efficacy and safety of pyrotinib in patients with HER2-positive metastatic breast cancer: A prospective real-world study. Frontiers in Pharmacology. 14. 1100556–1100556. 8 indexed citations

Xu, Binghe, Fei Ma, Tao Wang, et al.. (2023). A Phase IIb, single arm, multicenter trial of sacituzumab govitecan in Chinese patients with metastatic triple‐negative breast cancer who received at least two prior treatments. International Journal of Cancer. 152(10). 2134–2144. 27 indexed citations

10.

Fan, Yu, Xiaorong Zhong, Yu Wang, et al.. (2023). A prospective cohort study of clinical characteristics and outcomes in Chinese patients with estrogen receptor-negative/progesterone receptor-positive early breast cancer. Breast Cancer Research and Treatment. 200(2). 171–182. 4 indexed citations

11.

Liu, Zhiyue, Mei Liu, Ting Liang, et al.. (2023). Global longitudinal strain at 3 months after therapy can predict late cardiotoxicity in breast cancer. Cancer Medicine. 12(12). 13374–13387. 7 indexed citations

12.

Lin, Yunzhu, et al.. (2023). Efficacy and safety of esketamine for sedation among patients undergoing gastrointestinal endoscopy: a systematic review and meta-analysis. BMC Anesthesiology. 23(1). 204–204. 11 indexed citations

13.

Zeng, Lijun, Xin‐hui Xie, Ting Luo, et al.. (2021). Progress of radiotherapy after breast-conserving surgery combined with silicone prosthesis reconstruction. SHILAP Revista de lepidopterología.

14.

Kang, Wenli, et al.. (2021). Role of maintenance strategies in advanced epithelial ovarian cancer: a systematic review, network meta-analysis and cost-effectiveness analysis protocol. BMJ Open. 11(12). e051037–e051037. 1 indexed citations

15.

Yang, Qing, Xiaorong Zhong, Wei Zhang, et al.. (2021). Cost-effectiveness of different surgical treatment approaches for early breast cancer: a retrospective matched cohort study from China. BMC Cancer. 21(1). 107–107. 7 indexed citations

16.

Xie, Yuxin, Unnur Valdimarsdóttir, Chengshi Wang, et al.. (2020). Public health insurance and cancer‐specific mortality risk among patients with breast cancer: A prospective cohort study in China. International Journal of Cancer. 148(1). 28–37. 26 indexed citations

17.

Wang, Xin, et al.. (2020). Optimum duration of adjuvant trastuzumab in treatment of human epidermal growth factor receptor-2 positive early breast cancer: protocol for a network meta-analysis of randomised controlled trials. BMJ Open. 10(11). e035802–e035802. 1 indexed citations

18.

Li, Yi, Chengcheng Gong, Qianyi Lu, et al.. (2020). Real-World Data of Triplet Combination of Trastuzumab, Lapatinib, and Chemotherapy in HER2-Positive Metastatic Breast Cancer: A Multicenter Retrospective Study. Frontiers in Oncology. 10. 271–271. 10 indexed citations

19.

Luo, Ting. (2011). Differential diagnosis between pancreatic cancer and chronic pancreatitis by enhanced scanning of both CT and MRI. 1 indexed citations

20.

Luo, Ting, et al.. (2011). Aspirin use and breast cancer risk: a meta-analysis. Breast Cancer Research and Treatment. 131(2). 581–587. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact